Summary
Drug binding in the interstitial fluid as well as in the plasma must be taken into account when considering the pharmacokinetics of drugs which are highly bound to plasma proteins and have a relatively small apparent volume of distribution (V). The half-life and apparent volume of distribution of such a drug can be affected significantly by changes in the extent of binding of the drug in both the plasma and the interstitial fluid. An alteration in the fraction of drug in the tissues which is unbound will primarily affect the pharmacokinetics of drugs which have a relatively large apparent volume of distribution. The effect of changes in the plasma free fraction of drug (fP) on tissue binding can be deduced from a plot of fP versus V, but not from a plot of fP versus β.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gibaldi M, Levy G, McNamara PJ (1978) Effect of plasma protein and tissue binding on the biological half-life of drugs. Clin Pharmacol Ther 24: 1–4
Gibaldi M, McNamara PJ (1977) Tissue binding of drugs. J Pharm Sci 66: 1211–1212
Gibaldi M, McNamara PJ (1978) Apparent volumes of distribution and drug binding to plasma proteins and tissues. Eur J Clin Pharmacol 13: 373–378
Gillette JR (1971) Factors affecting drug metabolism. Ann NY Acad Sci 179: 43–66
Gleichmann W, Backmann GW, Dengler HJ, Dudeck J (1973) Effect of hormonal contraceptives and pregnancy on serum protein pattern. Eur J Clin Pharmacol 5: 218–225
Gugler R, Shoeman DW, Huffman DH, Cohlmia JB, Azarnoff DL (1975) Pharmacokinetics of drugs in patients with nephrotic syndrome. J Clin Invest 55: 1182–1189
Jensen H, Rossing N, Andersen SB, Jarnum S (1967) Albumin metabolism in the nephrotic syndrome in adults. Clin Sci 33: 445–457
Jusko WJ, Gretch M (1976) Plasma and tissue binding of drugs in pharmacokinetics. Drug Metab Rev 5: 43–140
Levy G, Lai C-M, Yacobi A (1978) Comparative pharmacokinetics of coumarin anticoagulants XXXII: Interindividual differences in binding of warfarin and dicoumarol in rat liver and implications for physiological pharmacokinetic modelling. J Pharm Sci 67: 229–231
Øie S, Tozer TN (1979) Effect of altered plasma protein binding on apparent volume of distribution. J Pharm Sci 68: 1203–1205
Plantin L-O, Ahlinder S, Norberg R, Birke G (1971) The distribution of proteins between intra- and extravascular spaces in health and disease. Acta Med Scand 189: 309–314
Tillement J-P, Lhoste F, Giudicelli JF (1978) Diseases and drug protein binding. Clin Pharmacokinet 3: 144–154
Wagner JG (1971) Biopharmaceutics and Relevant Pharmacokinetics, p 260. Drug Intelligence Publications, Hamilton, Illinois
Wilkinson GR, Shand DG (1975) A physiologic approach to hepatic drug clearance. Clin Pharmacol Ther 18: 377–390
Yacobi A, Lai, C-M, Levy G (1977) Comparative pharmacokinetics of coumarin anticoagulants XXXI: Effect of plasma protein binding on distribution kinetics of dicoumarol in rats. J Pharm Sci 66: 1741–1743
Yacobi A, Levy G (1975) Comparative pharmacokinetics of coumarin anticoagulants XIV: Relationship between protein binding, distribution, and elimination kinetics in rats. J Pharm Sci 64: 1660–1664
Yacobi A, Levy G (1979) Effect of serum protein binding on sulfisoxazole distribution, metabolism, and excretion in rats. J Pharm Sci 68: 742–746
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Faed, E.M. Protein binding of drugs in plasma, interstitial fluid and tissues: Effect on pharmacokinetics. Eur J Clin Pharmacol 21, 77–81 (1981). https://doi.org/10.1007/BF00609592
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609592